500
Participants
Start Date
March 21, 2023
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2030
Hybrid DEB approach with drug-eluting balloon
If a patient is randomized to the hybrid DEB approach, lesion preparation of the SB with non-compliant balloon (NC) is mandatory before DEB application. The application of DEB can be performed if acceptable result of the lesion preparation is obtained (at least TIMI III flow and no flow limiting dissection). The drug- eluting balloon used in this study is the CE- marked Magic Touch Sirolimus Coated Balloon Catheter (Concept Medical, Gujarat, India). The size of the DEB is measured on a ratio 1:1 on reference diameter of the SB. The DEB balloon is inflated for 60 seconds, or two times more than 30 seconds if long duration inflations are not possible. Finally low pressure kissing inflation with the same DEB in place, and Proximal Optimization Therapy (POT) are performed. In case of SB occlusion, or flow limiting dissections in non-Left Main (LM) bifurcations and \< TIMI 3 flow or 70-99% residual stenosis in LM bifurcations, cross- over to two-stent technique is performed.
Two-stent strategy
When randomized to the conventional two-stent strategy, TAP/T or Culotte stenting is performed. First lesion preparation of the SB is mandatory. The drug-eluting stent (Supraflex stent) can be placed in the SB if acceptable result of the lesion preparation is obtained and is measured on a 1:1 ratio on reference diameter of the SB. Finally, kissing inflation and POT are mandatory.
RECRUITING
Catharina Hospital, Eindhoven
Collaborators (1)
Catharina Ziekenhuis Eindhoven
OTHER
Albert Schweitzer Hospital
OTHER
Onze Lieve Vrouwe Gasthuis
OTHER
Maasstad Hospital
OTHER
The Elisabeth-TweeSteden Hospital
OTHER
St. Antonius Hospital
OTHER
Frisius Medisch Centrum
OTHER
Meander Medical Center
OTHER
VieCuri Medical Centre
OTHER
Haga Hospital
OTHER
Rijnstate Hospital
OTHER
Jeroen Bosch Ziekenhuis
OTHER
Cathreine BV
OTHER